Connor, Clark & Lunn Investment Management Ltd. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2022. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2023$17,429
-68.8%
15,562
-71.1%
0.00%
Q1 2023$55,948
-12.4%
53,796
-5.7%
0.00%
Q4 2022$63,878
-16.0%
57,034
-15.1%
0.00%
Q3 2022$76,000
+2.7%
67,170
+34.3%
0.00%
Q2 2022$74,000
-59.1%
50,029
-36.9%
0.00%
-100.0%
Q1 2022$181,00079,2520.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders